The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types
Open accessPublished version of a preprint
Abstract
A novel variant of the SARS-CoV-2 virus carrying a point mutation in the Spike protein (D614G) has recently emerged and rapidly surpassed others in prevalence. This mutation is in linkage disequilibrium with an ORF1b protein variant (P314L), making it difficult to discern the functional significance of the Spike D614G mutation from population genetics alone. Here, we perform site-directed mutagenesis on wild-type human-codon-optimized Spike to introduce the D614G variant. Using multiple human cell lines, including human lung epithelial cells, we found that the lentiviral particles pseudotyped with Spike D614G are more effective at transducing cells than ones pseudotyped with wild-type Spike. The increased transduction with Spike D614G ranged from 1.3- to 2.4-fold in Caco-2 and Calu-3 cells expressing endogenous ACE2 and from 1.5- to 7.7-fold in A549 ACE2 and Huh7.5 ACE2 overexpressing ACE2. Furthermore, trans -complementation of SARS-CoV-2 virus with Spike D614G showed an increased infectivity in human cells. Although there is minimal difference in ACE2 receptor binding between the D614 and G614 Spike variants, the G614 variant is more resistant to proteolytic cleavage, suggesting a possible mechanism for the increased transduction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Structural basis of receptor recognition by SARS-CoV-2
Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661
Nextstrain: real-time tracking of pathogen evolution
Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154
Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., Ren, L., Guo, L., Guo, R., Chen, T., Hu, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15562-9 · Cited by 3,097
Ziegler, C. G. K., Allon, S. J., Nyquist, S. K., Mbano, I. M., Miao, V. N., Tzouanas, C. N., Cao, Y., Yousif, A. S., Bals, J., Hauser, B. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.035 · Cited by 2,284
Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.022 · Cited by 1,852
Spike mutation D614G alters SARS-CoV-2 fitness
Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., et al. (2021) · Nature · doi:10.1038/s41586-020-2895-3 · Cited by 1,558
Developing Covid-19 Vaccines at Pandemic Speed
Lurie, N., Saville, M., Hatchett, R., & Halton, J. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2005630 · Cited by 1,557
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.012 · Cited by 1,420
Research works printed but not linked: 17
- Andreatta, 2016, Gapped sequence alignment using artificial neural networks: application to the MHC class I system, Bioinformatics, 32, 511, 10.1093/bioinformatics/btv639 · DOI · Paper page
- Becerra-Flores, 2020, Sars‐cov‐2 viral spike G614 mutation exhibits higher case fatality rate, International Journal of Clinical Practice, 74, 10.1111/ijcp.13525 · DOI · Paper page
- Bestle, 2020, TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets, 10.1101/2020.04.15.042085 · DOI
- Bhattacharyya, 2020, Global spread of SARS-CoV-2 subtype with spike protein mutation D614G is shaped by human genomic variations that regulate expression of TMPRSS2 and MX1 genes, 10.1101/2020.05.04.075911 · DOI
- Dorp, 2020, No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2, 10.1101/2020.05.21.108506 · DOI
- Heald-Sargent, 2012, Ready, set, fuse! the coronavirus spike protein and acquisition of fusion competence, Viruses, 4, 557, 10.3390/v4040557 · DOI · Paper page
- Hu, 2020, The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity and decreases neutralization sensitivity to individual convalescent sera, 10.1101/2020.06.20.161323 · DOI
- Jiang, 2020, Bimodular effects of D614G mutation on the spike glycoprotein of SARS-CoV-2 enhance protein processing, membrane fusion, and viral infectivity, Signal Transduction and Targeted Therapy, 5, 10.1038/s41392-020-00392-4 · DOI
- Moore, 2004, Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2, Journal of Virology, 78, 10628, 10.1128/JVI.78.19.10628-10635.2004 · DOI · Paper page
- Ozono, 2020, Naturally mutated spike proteins of SARS-CoV-2 variants show differential levels of cell entry, 10.1101/2020.06.15.151779 · DOI
- Ren, 2006, Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus, Journal of General Virology, 87, 1691, 10.1099/vir.0.81749-0 · DOI · Paper page
- Sarkizova, 2020, A large peptidome dataset improves HLA class I epitope prediction across most of the human population, Nature Biotechnology, 38, 199, 10.1038/s41587-019-0322-9 · DOI · Paper page
- Shu, 2017, GISAID: global initiative on sharing all influenza data - from vision to reality, Eurosurveillance, 22, 10.2807/1560-7917.ES.2017.22.13.30494 · DOI · Paper page
- Wagner C, Roychoudhury P, Hadfield J, Hodcroft E, Lee J, Moncla L, Müller N, Behrens C, Meei-Li Huang PM, Pepper G, Shrestha L, Xie H, Neher R, Baird G, Greninger A, Jerome K, Bedford T. 2020. Comparing Viral Load and Clinical Outcomes in Washington State Across D614G Mutation in Spike Protein of SARS-CoV-2.
- Walls, 2020, Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell, 181, 281, 10.1016/j.cell.2020.02.058 · doi:10.1016/j.cell.2020.02.058 · Paper page
- Yi, 2020, Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies, Cellular & Molecular Immunology, 17, 621, 10.1038/s41423-020-0458-z · DOI · Paper page
- Zhang, 2020, SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity, Nature Communications, 11, 10.1038/s41467-020-19808-4 · DOI · Paper page
Cited by
Spike mutation D614G alters SARS-CoV-2 fitness
Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., et al. (2021) · Nature · doi:10.1038/s41586-020-2895-3 · Cited by 1,558
Distinct conformational states of SARS-CoV-2 spike protein
Cai, Y., Zhang, J., Xiao, T., Peng, H., Sterling, S. M., Walsh, R. M., Rawson, S., Rits-Volloch, S., & Chen, B. (2020) · Science · doi:10.1126/science.abd4251 · Cited by 1,221
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
Wang, M.-Y., Zhao, R., Gao, L.-J., Gao, X.-F., Wang, D.-P., & Cao, J.-M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.587269 · Cited by 874
Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells
Daniloski, Z., Jordan, T. X., Wessels, H.-H., Hoagland, D. A., Kasela, S., Legut, M., Maniatis, S., Mimitou, E. P., Lu, L., Geller, E., et al. (2021) · Cell · doi:10.1016/j.cell.2020.10.030 · Cited by 573
Self-citationSARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity
Ozono, S., Zhang, Y., Ode, H., Sano, K., Tan, T. S., Imai, K., Miyoshi, K., Kishigami, S., Ueno, T., Iwatani, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21118-2 · Cited by 535
Metadata
- Authors
- Daniloski, Z., Jordan, T. X., Ilmain, J. K., Guo, X., Bhabha, G., tenOever, B. R., & Sanjana, N. E.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2021-02-11
- Volume
- 10
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W3129126893
- Cited by
- 232
- References
- 13
- FWCI
- 14.14
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0/ (am)
- creativecommons.org/licenses/by/4.0/ (tdm)
- Funders
- American Heart Association (20POST35220040)
- National Institute of Allergy and Infectious Diseases (R01AI123155, R01AI147131)
- Pew Charitable Trusts (PEW-00033055)
- Searle Scholars Program (SSP-2018-2737)
- Defense Advanced Research Projects Agency (HR0011-20-2-0040, D18AP00053)
- National Human Genome Research Institute (DP2HG010099)
- National Cancer Institute (R01CA218668)
- Sidney Kimmel Foundation
- Melanoma Research Alliance
- Brain and Behavior Research Foundation
- NIH (R00HG008171)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types. https://app.cochat.ai/papers/10.7554/elife.65365
- The paper
- Daniloski, Z., Jordan, T. X., Ilmain, J. K., Guo, X., Bhabha, G., tenOever, B. R., & Sanjana, N. E. (2021). The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types. eLife. https://doi.org/10.7554/elife.65365
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.